speb/financial-data huggingface dataset:
KLIC balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -24707000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 5292000.00
KLIC cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 4028000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 3197000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 9213000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Other Properties: 30827000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 199000000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Payables: 102575000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 141454000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10582000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
KLIC income_statement (quarterly, 2025-12-31) — Pretax Income: 22539000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
KLIC cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
KLIC cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -89000000.00
KLIC cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2676000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 117613000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Receivables: 215779000.00
KLIC income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 100670000.00
KLIC income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3959000.00
KLIC cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -114000.00
KLIC cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -6712000.00
KLIC income_statement (quarterly, 2025-12-31) — Research And Development: 40376000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1205569000.00
KLIC cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
KLIC cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 185000000.00
KLIC cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1000.00
KLIC income_statement (quarterly, 2025-12-31) — Selling General And Administration: 40759000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Share Issued: 85364000.00
KLIC income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
KLIC cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5330000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 825035000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 750221000.00
KLIC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
KLIC income_statement (quarterly, 2025-12-31) — Tax Provision: 5743000.00
KLIC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
KLIC balance_sheet (quarterly, 2025-12-31) — Total Assets: 1114640000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 825035000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Debt: 36982000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 825035000.00
KLIC income_statement (quarterly, 2025-12-31) — Total Expenses: 181805000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 289605000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 200426000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 92728000.00
KLIC income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 17820000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 33683000.00
KLIC income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
KLIC income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
KLIC balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 16851000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 33041000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 976177000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Work In Process: 53203000.00
KLIC balance_sheet (quarterly, 2025-12-31) — Working Capital: 717337000.00
KLIC income_statement (quarterly, 2026-03-31) — +Operating Expense: 81138000.00
KLIC income_statement (quarterly, 2026-03-31) — +Total Revenue: 242621000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 85445000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 255610000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -161549000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
KLIC cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 307000.00
KLIC cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 307000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 7881000.00
KLIC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 52327000.00
KLIC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.67
KLIC cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 282128000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 29876000.00
KLIC cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4077000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 39786000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Capital Stock: 627269000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 337864000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 487864000.00
KLIC cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 283957000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Cash Financial: 53907000.00
KLIC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -283000.00
KLIC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 45368000.00
KLIC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 10271000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 36848000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -10592000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Inventory: -30070000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -359000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Payable: 26256000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 26256000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 8252000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Receivables: -39896000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -10592000.00
KLIC cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -35817000.00
KLIC cash_flow (quarterly, 2026-03-31) — Changes In Cash: 55356000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Common Stock: 627269000.00
KLIC cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 857546000.00
KLIC cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -165000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 6699000.00
KLIC income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 122917000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 46409000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Assets: 982317000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6192000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6192000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 50749000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 50749000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 233520000.00
KLIC cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -367000.00
KLIC cash_flow (quarterly, 2026-03-31) — Deferred Tax: -367000.00
KLIC cash_flow (quarterly, 2026-03-31) — Depreciation: 3671000.00
KLIC cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3978000.00
KLIC cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3978000.00
KLIC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 53121000.00
KLIC income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.66
KLIC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 35148000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 10727000.00
KLIC income_statement (quarterly, 2026-03-31) — EBIT: 42546000.00
KLIC income_statement (quarterly, 2026-03-31) — EBITDA: 46524000.00
KLIC cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 380000.00
KLIC cash_flow (quarterly, 2026-03-31) — End Cash Position: 337864000.00
KLIC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -283000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Finished Goods: 78832000.00
KLIC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 6194000.00
KLIC cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -362000.00
KLIC cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
KLIC cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -74000.00
KLIC income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -23460000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Goodwill: 69522000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 74506000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 255610000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 253394000.00
KLIC income_statement (quarterly, 2026-03-31) — Gross Profit: 119704000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 10000000.00
KLIC income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 22653000.00
KLIC income_statement (quarterly, 2026-03-31) — Interest Expense: 37000.00
KLIC income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 37000.00
KLIC income_statement (quarterly, 2026-03-31) — Interest Income: 3980000.00
KLIC income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3980000.00
KLIC cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 37000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -64647000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Inventory: 206294000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 857546000.00
KLIC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 45368000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 17881000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 17881000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 2182000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Leases: 34139000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 33594000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 33594000.00
KLIC cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -118000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 146577000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 371000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -165000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 978000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 35148000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 35148000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Interest Income: 3943000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 49000000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -118000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -118000.00
KLIC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3943000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Net PPE: 91845000.00
KLIC cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4003000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 783040000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 16144000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 34892000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 16144000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 34892000.00
KLIC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 46524000.00
KLIC income_statement (quarterly, 2026-03-31) — Normalized Income: 35148000.00
KLIC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 10271000.00
KLIC cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 814000.00
KLIC income_statement (quarterly, 2026-03-31) — Operating Income: 38566000.00
KLIC income_statement (quarterly, 2026-03-31) — Operating Revenue: 242621000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 52329000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 32549000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 4722000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -23460000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4984000.00
KLIC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 26000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3291000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 9143000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Properties: 33921000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 150000000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Payables: 118825000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 165234000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6623000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
KLIC income_statement (quarterly, 2026-03-31) — Pretax Income: 42509000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
KLIC cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
KLIC cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -95000000.00
KLIC cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4077000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Raw Materials: 128868000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Receivables: 255610000.00
KLIC income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 122917000.00
KLIC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3978000.00
KLIC cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -118000.00
KLIC cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -165000.00
KLIC income_statement (quarterly, 2026-03-31) — Research And Development: 38396000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1229990000.00
KLIC cash_flow (quarterly, 2026-03-31) — Sale Of Business: 371000.00
KLIC cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 144000000.00
KLIC cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 74000.00
KLIC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 42742000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Share Issued: 85364000.00
KLIC income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
KLIC cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6991000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 857546000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 783040000.00
KLIC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
KLIC income_statement (quarterly, 2026-03-31) — Tax Provision: 7361000.00
KLIC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.17
KLIC balance_sheet (quarterly, 2026-03-31) — Total Assets: 1185984000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 857546000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Debt: 39786000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 857546000.00
KLIC income_statement (quarterly, 2026-03-31) — Total Expenses: 204055000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 328438000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 203667000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 94918000.00
KLIC income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 38566000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 22653000.00
KLIC income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
KLIC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
KLIC balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 17289000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 33035000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 976253000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Work In Process: 63241000.00
KLIC balance_sheet (quarterly, 2026-03-31) — Working Capital: 748797000.00
KLIN.SW income_statement (annual, 2022-03-31) — +Operating Expense: 105362000.00
KLIN.SW income_statement (annual, 2022-03-31) — +Total Revenue: 158608000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Accounts Payable: 33844000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Accounts Receivable: 40557000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -67234000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -158000.00
KLIN.SW income_statement (annual, 2022-03-31) — Amortization: 419000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 172000.00
KLIN.SW income_statement (annual, 2022-03-31) — Basic Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2022-03-31) — Basic EPS: -2.45
KLIN.SW cash_flow (annual, 2022-03-31) — Beginning Cash Position: 22577000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Capital Expenditure: -11575000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 7720000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 7720000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Change In Inventory: -52512000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 14747000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Change In Payable: 19177000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Change In Receivables: -22604000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Change In Working Capital: -43466000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Changes In Cash: -14839000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Common Stock Equity: 104723000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Construction In Progress: 8965000.00
KLIN.SW income_statement (annual, 2022-03-31) — Cost Of Revenue: 69514000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Current Assets: 214413000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Current Liabilities: 145216000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Current Provisions: 5443000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 900000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Depreciation: 4563000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 4563000.00
KLIN.SW income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 4563000.00
KLIN.SW income_statement (annual, 2022-03-31) — Depreciation Income Statement: 4144000.00
KLIN.SW income_statement (annual, 2022-03-31) — Diluted Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2022-03-31) — Diluted EPS: -2.45
KLIN.SW income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — EBIT: -19048000.00
KLIN.SW income_statement (annual, 2022-03-31) — EBITDA: -14485000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -18000.00
KLIN.SW cash_flow (annual, 2022-03-31) — End Cash Position: 7720000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Financing Cash Flow: 40787000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Finished Goods: 8165000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Free Cash Flow: -66112000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 928000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 832000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 40715000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Gross PPE: 113227000.00
KLIN.SW income_statement (annual, 2022-03-31) — Gross Profit: 89094000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 38000.00
KLIN.SW income_statement (annual, 2022-03-31) — Interest Expense: 620000.00
KLIN.SW income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 620000.00
KLIN.SW income_statement (annual, 2022-03-31) — Interest Income: 157000.00
KLIN.SW income_statement (annual, 2022-03-31) — Interest Income Non Operating: 157000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Inventories Adjustments Allowances: -12625000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Inventory: 133025000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Invested Capital: 104723000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Investing Cash Flow: -1089000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 172000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 1304000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 1304000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Long Term Provisions: 14769000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 41156000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -21677000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -21677000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -21677000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -134000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Interest Income: -463000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 842000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 40787000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 6036000.00
KLIN.SW income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -463000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Net PPE: 45993000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -1797000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 34751000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 103891000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 9948000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1114000.00
KLIN.SW income_statement (annual, 2022-03-31) — Normalized EBITDA: -14485000.00
KLIN.SW income_statement (annual, 2022-03-31) — Normalized Income: -21677000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Operating Cash Flow: -54537000.00
KLIN.SW income_statement (annual, 2022-03-31) — Operating Income: -16268000.00
KLIN.SW income_statement (annual, 2022-03-31) — Operating Revenue: 158608000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 2324000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 832000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Other Inventories: 54130000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Other Non Cash Items: 5708000.00
KLIN.SW income_statement (annual, 2022-03-31) — Other Operating Expenses: 45232000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Other Properties: 23457000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Other Receivables: 24573000.00
KLIN.SW income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Payables: 41744000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Prepaid Assets: 600000.00
KLIN.SW income_statement (annual, 2022-03-31) — Pretax Income: -19668000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Properties: 39649000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -134000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Purchase Of Investment: 0.00
KLIN.SW cash_flow (annual, 2022-03-31) — Purchase Of PPE: -11441000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Raw Materials: 83000.00
KLIN.SW income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 69514000.00
KLIN.SW income_statement (annual, 2022-03-31) — Reconciled Depreciation: 4563000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Retained Earnings: 32950000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Sale Of Intangibles: 0.00
KLIN.SW cash_flow (annual, 2022-03-31) — Sale Of Investment: 842000.00
KLIN.SW cash_flow (annual, 2022-03-31) — Sale Of PPE: 9644000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Share Issued: 8840000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Stockholders Equity: 104723000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Tangible Book Value: 103891000.00
KLIN.SW income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
KLIN.SW income_statement (annual, 2022-03-31) — Tax Provision: 2009000.00
KLIN.SW income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.09
KLIN.SW balance_sheet (annual, 2022-03-31) — Taxes Receivable: 7900000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Assets: 273562000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Capitalization: 104723000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 104723000.00
KLIN.SW income_statement (annual, 2022-03-31) — Total Expenses: 174876000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 168839000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 59149000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 23623000.00
KLIN.SW income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -15675000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Total Tax Payable: 7900000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Work In Process: 83272000.00
KLIN.SW balance_sheet (annual, 2022-03-31) — Working Capital: 69197000.00
KLIN.SW income_statement (annual, 2023-03-31) — +Operating Expense: 141150000.00
KLIN.SW income_statement (annual, 2023-03-31) — +Total Revenue: 308961000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Accounts Payable: 27573000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Accounts Receivable: 71147000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -65002000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -161000.00
KLIN.SW income_statement (annual, 2023-03-31) — Amortization: 367000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 148000.00
KLIN.SW income_statement (annual, 2023-03-31) — Basic Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2023-03-31) — Basic EPS: 2.35
KLIN.SW cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7720000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Capital Expenditure: -18318000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 8718000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 8718000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Change In Inventory: 16156000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -5033000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Change In Payable: -5857000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Change In Receivables: -10611000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Change In Working Capital: -9057000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Changes In Cash: 711000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Common Stock Equity: 126609000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Construction In Progress: 150000.00
KLIN.SW income_statement (annual, 2023-03-31) — Cost Of Revenue: 144634000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Current Assets: 208415000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Current Liabilities: 126424000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Current Provisions: 4720000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 1200000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Depreciation: 4323000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 4323000.00
KLIN.SW income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 4323000.00
KLIN.SW income_statement (annual, 2023-03-31) — Depreciation Income Statement: 3956000.00
KLIN.SW income_statement (annual, 2023-03-31) — Diluted Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2023-03-31) — Diluted EPS: 2.35
KLIN.SW income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — EBIT: 22682000.00
KLIN.SW income_statement (annual, 2023-03-31) — EBITDA: 27005000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 287000.00
KLIN.SW cash_flow (annual, 2023-03-31) — End Cash Position: 8718000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2588000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Finished Goods: 7846000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Free Cash Flow: -2615000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 138000.00
KLIN.SW income_statement (annual, 2023-03-31) — General And Administrative Expense: 3700000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 732000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 71308000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Gross PPE: 123735000.00
KLIN.SW income_statement (annual, 2023-03-31) — Gross Profit: 164327000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 134000.00
KLIN.SW income_statement (annual, 2023-03-31) — Interest Expense: 1222000.00
KLIN.SW income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1222000.00
KLIN.SW income_statement (annual, 2023-03-31) — Interest Income: 180000.00
KLIN.SW income_statement (annual, 2023-03-31) — Interest Income Non Operating: 180000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Inventories Adjustments Allowances: -12499000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Inventory: 117588000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Invested Capital: 126609000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Investing Cash Flow: -17580000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 148000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 1333000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 1333000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Long Term Provisions: 11566000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 40727000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 20755000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 20755000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 20755000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -267000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Interest Income: -1042000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 174000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2588000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 10722000.00
KLIN.SW income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1042000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Net PPE: 58733000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -17487000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -8134000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 125877000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 13749000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1329000.00
KLIN.SW income_statement (annual, 2023-03-31) — Normalized EBITDA: 27005000.00
KLIN.SW income_statement (annual, 2023-03-31) — Normalized Income: 20755000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Operating Cash Flow: 15703000.00
KLIN.SW income_statement (annual, 2023-03-31) — Operating Income: 23177000.00
KLIN.SW income_statement (annual, 2023-03-31) — Operating Revenue: 308961000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 2125000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 732000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Other Inventories: 55325000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Other Non Cash Items: 157000.00
KLIN.SW income_statement (annual, 2023-03-31) — Other Operating Expenses: 46260000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Other Properties: 22701000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Other Receivables: 8228000.00
KLIN.SW income_statement (annual, 2023-03-31) — Other Special Charges: -6100000.00
KLIN.SW income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Payables: 31073000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Prepaid Assets: 600000.00
KLIN.SW income_statement (annual, 2023-03-31) — Pretax Income: 21460000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Properties: 60157000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -270000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Purchase Of Investment: -410000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Purchase Of PPE: -18048000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Raw Materials: 188000.00
KLIN.SW income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 144634000.00
KLIN.SW income_statement (annual, 2023-03-31) — Reconciled Depreciation: 4323000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Retained Earnings: 54836000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Sale Of Intangibles: 3000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Sale Of Investment: 584000.00
KLIN.SW cash_flow (annual, 2023-03-31) — Sale Of PPE: 561000.00
KLIN.SW income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 9000000.00
KLIN.SW income_statement (annual, 2023-03-31) — Selling General And Administration: 12700000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Share Issued: 8840000.00
KLIN.SW income_statement (annual, 2023-03-31) — Special Income Charges: 6100000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Stockholders Equity: 126609000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Tangible Book Value: 125877000.00
KLIN.SW income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
KLIN.SW income_statement (annual, 2023-03-31) — Tax Provision: 705000.00
KLIN.SW income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.03
KLIN.SW balance_sheet (annual, 2023-03-31) — Taxes Receivable: 2000000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Assets: 284444000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Capitalization: 126609000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 126609000.00
KLIN.SW income_statement (annual, 2023-03-31) — Total Expenses: 285784000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 157835000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 76029000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 31411000.00
KLIN.SW income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 23790000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Total Tax Payable: 3500000.00
KLIN.SW income_statement (annual, 2023-03-31) — Total Unusual Items: 6100000.00
KLIN.SW income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 6100000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Work In Process: 66728000.00
KLIN.SW balance_sheet (annual, 2023-03-31) — Working Capital: 81991000.00
KLIN.SW income_statement (annual, 2024-03-31) — +Operating Expense: 159966000.00
KLIN.SW income_statement (annual, 2024-03-31) — +Total Revenue: 303497000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Accounts Payable: 18910000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Accounts Receivable: 79904000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -68120000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -156000.00
KLIN.SW income_statement (annual, 2024-03-31) — Amortization: 275000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 148000.00
KLIN.SW income_statement (annual, 2024-03-31) — Basic Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2024-03-31) — Basic EPS: 1.95
KLIN.SW cash_flow (annual, 2024-03-31) — Beginning Cash Position: 8718000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Capital Expenditure: -8286000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 16506000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 16506000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -3701000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Change In Inventory: 2837000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 10887000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Change In Payable: -8775000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Change In Receivables: -6441000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Change In Working Capital: 545000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Changes In Cash: 8391000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Common Stock Equity: 140752000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Construction In Progress: 1304000.00
KLIN.SW income_statement (annual, 2024-03-31) — Cost Of Revenue: 128456000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Current Assets: 220396000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Current Liabilities: 128183000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Current Provisions: 5859000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 1000000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Depreciation: 5140000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 5140000.00
KLIN.SW income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 5140000.00
KLIN.SW income_statement (annual, 2024-03-31) — Depreciation Income Statement: 4865000.00
KLIN.SW income_statement (annual, 2024-03-31) — Diluted Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2024-03-31) — Diluted EPS: 1.95
KLIN.SW income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — EBIT: 24385000.00
KLIN.SW income_statement (annual, 2024-03-31) — EBITDA: 29525000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -603000.00
KLIN.SW cash_flow (annual, 2024-03-31) — End Cash Position: 16506000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Financing Cash Flow: -7780000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Finished Goods: 10041000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Free Cash Flow: 15200000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -71000.00
KLIN.SW income_statement (annual, 2024-03-31) — General And Administrative Expense: 3200000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 604000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 80060000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Gross PPE: 126913000.00
KLIN.SW income_statement (annual, 2024-03-31) — Gross Profit: 175041000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 15000.00
KLIN.SW income_statement (annual, 2024-03-31) — Interest Expense: 1830000.00
KLIN.SW income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1830000.00
KLIN.SW income_statement (annual, 2024-03-31) — Interest Income: 387000.00
KLIN.SW income_statement (annual, 2024-03-31) — Interest Income Non Operating: 387000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: -12414000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Inventory: 114415000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Invested Capital: 140752000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Investing Cash Flow: -7315000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 148000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 2325000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 2325000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Long Term Provisions: 12245000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 42487000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 17205000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 17205000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 17205000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -151000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Interest Income: -1443000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 334000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -4079000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -2512000.00
KLIN.SW income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1443000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Net PPE: 58793000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -7498000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -1567000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 140148000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 12858000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 1548000.00
KLIN.SW income_statement (annual, 2024-03-31) — Normalized EBITDA: 20525000.00
KLIN.SW income_statement (annual, 2024-03-31) — Normalized Income: 10339800.00
KLIN.SW cash_flow (annual, 2024-03-31) — Operating Cash Flow: 23486000.00
KLIN.SW income_statement (annual, 2024-03-31) — Operating Income: 15075000.00
KLIN.SW income_statement (annual, 2024-03-31) — Operating Revenue: 303497000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2864000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 604000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Other Inventories: 51244000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1659000.00
KLIN.SW income_statement (annual, 2024-03-31) — Other Operating Expenses: 44499000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Other Properties: 25267000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Other Receivables: 6256000.00
KLIN.SW income_statement (annual, 2024-03-31) — Other Special Charges: -9000000.00
KLIN.SW income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Payables: 23410000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Prepaid Assets: 900000.00
KLIN.SW income_statement (annual, 2024-03-31) — Pretax Income: 22555000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Properties: 57855000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
KLIN.SW cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -151000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
KLIN.SW cash_flow (annual, 2024-03-31) — Purchase Of PPE: -8135000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Raw Materials: 308000.00
KLIN.SW income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 128456000.00
KLIN.SW income_statement (annual, 2024-03-31) — Reconciled Depreciation: 5140000.00
KLIN.SW income_statement (annual, 2024-03-31) — Rent And Landing Fees: 3200000.00
KLIN.SW income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 3200000.00